Literature DB >> 3430139

Concentrations of mustard gas [bis(2-chloroethyl)sulfide] in the tissues of a victim of a vesicant exposure.

G Drasch1, E Kretschmer, G Kauert, L von Meyer.   

Abstract

An Iranian soldier died at a toxicological intensive care unit at Munich seven days after a vesicant exposure. At the autopsy the typical symptoms of mustard gas intoxication were found. The vesicant was detected qualitatively by gas chromatography-mass spectrometry (GC-MS) in the abdominal fat and quantified in the tissues and in the body fluids by the following method: (1) extraction by dichloromethane, (2) cleanup of the extracts by thin-layer chromatography (TLC) on silica plates, (3) extractive derivatization with gold-chloride, and (4) quantitative determination by electrothermal atomic absorption spectrometry (ET-AAS). The equal extracts, after heating, served for blanks. The following concentrations were found (milligrams of mustard gas/kilograms of tissue wet weight): brain 10.7, cerebrospinal fluid 1.9, liver 2.4, kidney 5.6; spleen 1.5, lung 0.8, muscle 3.9, fat 15.1, skin 8.4, skin with subcutaneous fatty tissue 11.8, liquid from a skin blister: below detection limit, blood 1.1, and urine: below detection limit.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3430139

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  15 in total

1.  2,6-Dithiopurine, a nucleophilic scavenger, protects against mutagenesis in mouse skin treated in vivo with 2-(chloroethyl) ethyl sulfide, a mustard gas analog.

Authors:  Stephen Boulware; Tammy Fields; Elizabeth McIvor; K Leslie Powell; Erika L Abel; Karen M Vasquez; Michael C MacLeod
Journal:  Toxicol Appl Pharmacol       Date:  2012-06-23       Impact factor: 4.219

2.  A recent exposure to mustard gas in the United States: clinical findings of a cohort (n = 247) 6 years after exposure.

Authors:  Yuruk Iyriboz
Journal:  MedGenMed       Date:  2004-10-22

3.  Detoxication of sulfur half-mustards by nucleophilic scavengers: robust activity of thiopurines.

Authors:  Jinyun Liu; K Leslie Powell; Howard D Thames; Michael C MacLeod
Journal:  Chem Res Toxicol       Date:  2010-03-15       Impact factor: 3.739

4.  2,6-Dithiopurine blocks toxicity and mutagenesis in human skin cells exposed to sulfur mustard analogues, 2-chloroethyl ethyl sulfide and 2-chloroethyl methyl sulfide.

Authors:  K Leslie Powell; Stephen Boulware; Howard Thames; Karen M Vasquez; Michael C MacLeod
Journal:  Chem Res Toxicol       Date:  2010-03-15       Impact factor: 3.739

5.  Sulforaphane induces phase II detoxication enzymes in mouse skin and prevents mutagenesis induced by a mustard gas analog.

Authors:  E L Abel; S Boulware; T Fields; E McIvor; K L Powell; J DiGiovanni; K M Vasquez; M C MacLeod
Journal:  Toxicol Appl Pharmacol       Date:  2012-11-30       Impact factor: 4.219

6.  Chronic health effects of sulphur mustard exposure with special reference to Iranian veterans.

Authors:  M Balali-Mood; Sh Mousavi; B Balali-Mood
Journal:  Emerg Health Threats J       Date:  2008-11-07

7.  Capsaicinoids, chloropicrin and sulfur mustard: possibilities for exposure biomarkers.

Authors:  Maija Pesonen; Kirsi Vähäkangas; Mia Halme; Paula Vanninen; Heikki Seulanto; Matti Hemmilä; Markku Pasanen; Tapio Kuitunen
Journal:  Front Pharmacol       Date:  2010-12-20       Impact factor: 5.810

8.  Commentary on: a review on delayed toxic effects of sulfur mustard in Iranian veterans.

Authors:  Amir Shadboorestan
Journal:  Daru       Date:  2012-12-26       Impact factor: 3.117

9.  Sulfur mustard toxicity following dermal exposure: role of oxidative stress, and antioxidant therapy.

Authors:  Victor Paromov; Zacharias Suntres; Milton Smith; William L Stone
Journal:  J Burns Wounds       Date:  2007-10-30

10.  Sulfur mustard research--strategies for the development of improved medical therapy.

Authors:  Kai Kehe; Frank Balszuweit; Judith Emmler; Helmut Kreppel; Marianne Jochum; Horst Thiermann
Journal:  Eplasty       Date:  2008-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.